COLGATE PALMOLIVE CO financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data COLGATE PALMOLIVE CO files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	15,195	15,454	15,544	15,693	16,471	17,421	17,967	19,457	20,101	20,382
Cost of revenue	6,072	6,174	6,313	6,368	6,454	7,046	7,719	8,131	7,940	8,131
Gross profit	9,123	9,280	9,231	9,325	10,017	10,375	10,248	11,326	12,161	12,251
Research and development	289	285	277	281	290	307	320	343	355	366
Selling, general and administrative	5,143	5,400	5,389	5,575	6,019	6,407	6,565	7,151	7,729	7,903
Operating income	3,955	3,707	3,694	3,554	3,885	3,332	2,893	3,984	4,268	3,306
Interest expense	155	156	195	193	184	120	167	287	292	267
Interest income	50	51	50	47	19	17	14	55	67	75
Pre-tax income	3,738	3,487	3,464	3,301	3,647	3,087	2,660	3,392	3,956	3,059
Income tax	1,152	1,313	906	774	787	749	693	937	907	798
Net income to minority interests	145	150	158	160	165	172	182	155	160	129
Net income	2,441	2,024	2,400	2,367	2,695	2,166	1,785	2,300	2,889	2,132
EBITDA	4,398	4,182	4,205	4,073	4,424	3,888	3,438	4,551	4,873	3,936
EPS, basic	2.74	2.30	2.76	2.76	3.15	2.56	2.13	2.78	3.53	2.64
EPS, diluted	2.72	2.28	2.75	2.75	3.14	2.55	2.13	2.77	3.51	2.63
Shares, basic (weighted)	892	882	871	859	857	845	836	827	819	809
Shares, diluted (weighted)	898	888	873	861	859	848	839	829	823	811
Dividend per share		1.59	1.66	1.71	1.75	1.79	1.86	1.91	2.48	2.08

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	1,315	1,535	726	883	888	832	775	966	1,096	1,288
Short-term investments								179	160	107
Receivables	1,411	1,480	1,400	1,440	1,264	1,297	1,504	1,586	1,521	1,675
Inventory	1,171	1,221	1,250	1,400	1,673	1,692	2,074	1,934	1,987	2,032
Other current assets	441	403	417	456	513	576	760	793	713	714
Total current assets	4,338	4,639	3,793	4,179	4,338	4,397	5,113	5,279	5,317	5,709
Property, plant and equipment	3,840	4,072	3,881	3,750	3,716	3,730	4,307	4,582	4,422	4,660
Lease right-of-use assets				502	521	527	478	491	529	531
Goodwill	2,107	2,218	2,530	3,508	3,824	3,284	3,352	3,410	3,272	3,122
Intangible assets	1,313	1,341	1,637	2,667	2,894	2,462	1,920	1,887	1,756	1,536
Other non-current assets	224	218	168	753	857	974	904	1,021	1,084	1,098
Total assets	12,123	12,676	12,161	15,034	15,920	15,040	15,731	16,393	16,046	16,330
Accounts payable	1,124	1,212	1,222	1,237	1,393	1,479	1,551	1,698	1,805	2,089
Accrued liabilities	309	325	275	340	401	353	329	403	437	420
Short-term debt	0	0	0	254	9	12	14	20	652	1,115
Total current liabilities	3,305	3,408	3,341	4,038	4,404	4,051	4,004	4,741	5,759	6,853
Long-term debt	6,520	6,566	6,354	7,333	7,334	7,194	8,741	8,219	7,289	6,871
Lease liabilities				491	476	451	397	420	456	448
Other non-current liabilities	2,035	2,255	2,034	2,598	2,655	2,429	1,797	2,115	2,111	2,060
Total liabilities	12,106	12,433	11,964	14,476	14,819	14,069	14,925	15,436	15,502	15,965
Total debt	6,520	6,566	6,354	7,587	7,343	7,206	8,755	8,239	7,005	7,839
Paid-in capital	1,691	1,984	2,204	2,488	2,969	3,269	3,546	3,808	4,181	4,322
Retained earnings	19,922	20,531	21,615	22,501	23,699	24,350	24,573	25,289	26,145	26,595
Treasury stock	-19,135	-20,181	-21,196	-22,063	-23,045	-24,089	-25,128	-26,017	-27,358	-28,450
Other comprehensive income	-4,180	-3,855	-4,188	-4,273	-4,345	-4,386	-4,055	-3,937	-4,222	-3,879
Shareholders' equity	-243	-60	-102	117	743	609	401	609	212	54
Minority interests	260	303	299	441	358	362	405	348	332	311
Total equity	17	243	197	558	1,101	971	806	957	544	365
Total liabilities and equity	12,123	12,676	12,161	15,034	15,920	15,040	15,731	16,393	16,046	16,330
Shares outstanding	883	875	863	855	850	840	830	821	813	801

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	2,586	2,174	2,558	2,527	2,860	2,338	1,967	2,455	3,049	2,261
Depreciation and amortization	443	475	511	519	539	556	545	567	605	630
Stock-based compensation	123	127	109	100	107	135	125	122	135	155
Deferred income tax	71	108	53	19	-143	-37	-163	-135	-33	-156
Change in receivables	-17	-15	-79	19	138	-84	-227	-37	-56	-16
Change in inventory	-4	-8	-58	-77	-251	-72	-333	194	-100	109
Change in payables	100	-96	18	36	520	14	-115	309	516
Cash from operations	3,141	3,054	3,056	3,133	3,719	3,325	2,556	3,745	4,107	4,198
Capital expenditures	-593	-553	-436	-335	-409	-567	-696	-705	-561	-564
Acquisitions	-5	0	-728	-1,711	-353	0	-809	0	0	-293
Purchases of investments	-336	-347	-169	-184	-143	-141	-470	-506	-574	-698
Sales and maturities of investments	378	391	156	131	124	141	322	502	564	752
Cash from investing	-499	-471	-1,170	-2,099	-779	-592	-1,601	-742	-534	-817
Debt issued	7,438	4,779	7,176	8,059
Debt repaid	-7,274	-4,808	-7,355	-6,611
Stock issued	386	507	329	498	874	424	418	380	638	101
Share buybacks	-1,335	-1,399	-1,238	-1,202	-1,476	-1,320	-1,308	-1,128	-1,739	-1,210
Dividends paid	-1,508	-1,529	-1,591	-1,614	-1,654	-1,679	-1,691	-1,749	-1,789	-1,823
Cash from financing	-2,233	-2,450	-2,679	-870	-2,919	-2,774	-952	-2,793	-3,389	-3,256
Exchange rate effect	-64	87	-16	-7	-16	-15	-60	-19	-54	67
Net change in cash	345	220	-809	157	5	-56	-57	191	130	192
Free cash flow	2,548	2,501	2,620	2,798	3,310	2,758	1,860	3,040	3,546	3,634
Interest paid	162	150	194	185	188	194	151	280	302	270
Income taxes paid	932	1,037	847	803	845	890	945	937	933	913

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $86.06 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	60.4%	Gross profit / revenue.
Operating margin	14.9%	Operating income / revenue.
EBITDA margin	17.9%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	14.0%	Pre-tax income / revenue.
Net margin	9.7%	Net income / revenue.
FCF margin	18.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	21.2%	Cash from operations / revenue.
Effective tax rate	26.5%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	863.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	12.1%	Net income / average total assets.
Return on invested capital (ROIC)	34.4%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	39.2%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.8%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.8%	Capital expenditures / revenue.
D&A / revenue	3.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	1.4%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	4.3%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	4.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	0.7%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	6.1%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	4.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-22.5%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	4.5%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-3.2%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-19.2%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	4.6%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-2.3%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-26.2%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	6.1%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-4.6%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-25.1%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	7.3%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-3.5%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	2.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	18.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	2.5%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	2.5%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	25.0%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	1.9%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	-16.1%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	3.8%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	3.5%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-74.5%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-48.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-40.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	1.8%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	1.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	0.5%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-1.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.03x	Current assets / current liabilities.
Quick ratio	0.54x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.22x	(Cash + short-term investments) / current liabilities.
Debt / equity	33.1x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	46.6%	Total debt / total assets.
Liabilities / assets	96.6%	Total liabilities / total assets.
Net debt	$6.45B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	1.71x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	12.3x	Operating income / interest expense.
Working capital	$160.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	27.4%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$4.36B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.25x	Revenue / average total assets.
Fixed asset turnover	4.54x	Revenue / average property, plant and equipment.
Inventory turnover	3.82x	Cost of revenue / average inventory.
Days inventory	96 days	365 x average inventory / cost of revenue.
Receivables turnover	10.7x	Revenue / average receivables.
Days sales outstanding	34 days	365 x average receivables / revenue.
Days payables	93 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	37 days	Days inventory + days sales outstanding - days payables.
FCF conversion	189.3%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	13.4%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.54	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$26.25	Revenue / diluted weighted shares.
FCF per share	$4.81	Free cash flow / diluted weighted shares.
Operating cash flow per share	$5.56	Cash from operations / diluted weighted shares.
Book value per share	$0.29	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$5.44	Tangible book value / shares outstanding.
Cash per share	$1.71	(Cash + short-term investments) / shares outstanding.
Payout ratio	89.4%	Dividends paid / net income, when net income is positive.
Dividends / FCF	47.2%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	33.5%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$68.60B	Share price x shares outstanding.
Enterprise value	$75.06B	Market cap + total debt - cash - short-term investments.
P/E	33.7x	Market cap / net income. Only when net income is positive.
P/S	3.26x	Market cap / revenue.
P/B	291x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	17.8x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	15.4x	Market cap / cash from operations, when positive.
EV/Sales	3.57x	Enterprise value / revenue.
EV/EBIT	24.0x	Enterprise value / operating income, when both are positive.
EV/EBITDA	19.9x	Enterprise value / EBITDA, when both are positive.
EV/FCF	19.5x	Enterprise value / free cash flow, when both are positive.
FCF yield	5.6%	Free cash flow / market cap.
Earnings yield	3.0%	Net income / market cap (the inverse of P/E).
Dividend yield	2.7%	Dividends paid over the period / market cap.
Shareholder yield	4.5%	(Dividends paid + share buybacks) / market cap.
PEG	4.62x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was COLGATE PALMOLIVE CO's revenue in fiscal 2025?

COLGATE PALMOLIVE CO reported revenue of $20.38B for fiscal 2025, 1.4% higher than the year before.

Was COLGATE PALMOLIVE CO profitable in fiscal 2025?

Yes. Net income was $2.13B, a net margin of 10.5%.

How much free cash flow did COLGATE PALMOLIVE CO generate in fiscal 2025?

Cash from operations of $4.20B minus capital expenditures of $564.0M left free cash flow of $3.63B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to COLGATE PALMOLIVE CO